Methylglyoxal-derived hydroimidazolone-1

Methylglyoxal-derived hydroimidazolone-1 has been studied in 2 papers since 2023: 2 observational studies in people; 1 in the past year. The newest paper, Jan 23, 2026: “Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes”.

Intervention

2 papers study it3 findingsUpdated

See all 2 papers on methylglyoxal-derived hydroimidazolone-1

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”
Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predispositionClinical nutrition (Edinburgh, Scotland)2023doi:10.1016/j.clnu.2023.08.006

None of its findings points the other way.

Cells and humans: a single group. Worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: Japan Society for the Promotion of Science and 2 more
  • Humans2

What did studies of methylglyoxal-derived hydroimidazolone-1 find?

2

Studies of methylglyoxal-derived hydroimidazolone-1 measured 2 outcomes: Akt phosphorylation and glucose uptake.

Akt phosphorylation

downin mouse cells1

1 study
  1. Methylglyoxal-derived hydroimidazolone-1 decreases Akt phosphorylation in mouse cells.

    “pre-treatment with MG-H1 inhibited insulin-stimulated phosphorylation of Akt”

    CellsC2C12 skeletal myocytes

    Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes

    Diabetes, obesity & metabolism

More on Akt phosphorylation

Glucose uptake

downin mouse cells1

1 study
  1. Methylglyoxal-derived hydroimidazolone-1 decreases glucose uptake in mouse cells.

    “pre-treatment with MG-H1 inhibited insulin-stimulated phosphorylation of Akt and glucose uptake, via the activation of mechanistic target of rapamycin complex 2 (mTORC2).”

    CellsC2C12 skeletal myocytes

    Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes

    Diabetes, obesity & metabolism

What is methylglyoxal-derived hydroimidazolone-1 linked with?

1

Studies link methylglyoxal-derived hydroimidazolone-1 with dementia.

Dementia

upin humans1HR 1.24

1 study
  1. Methylglyoxal-derived hydroimidazolone-1 is associated with dementia in humans (Free from dementia at baseline; multivariable-adjusted analysis) (HR 1.24, 95% CI 1.02–1.52).

    “Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”

    HumansFree from dementia at baseline; multivariable-adjusted analysisHighest versus lowest tertile of intakeMedian follow-up of 11.9 yearsn = 93,830

    Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition

    Clinical nutrition (Edinburgh, Scotland)

More on Dementia

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months